AMPH Amphastar Pharmaceuticals
- 41.570
- +0.380+0.92%
Amphastar Pharmaceuticals News
Capital One Financial Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $70
Analysts' Top Healthcare Picks: Align Tech (ALGN), Amphastar Pharmaceuticals (AMPH)
Bank of America Securities Reaffirms Their Hold Rating on Amphastar Pharmaceuticals (AMPH)
Amphastar Pharma Analyst Ratings
Amphastar Pharmaceuticals (AMPH) Receives a Buy From Piper Sandler
Amphastar Pharma Analyst Ratings
Amphastar Pharmaceuticals Holds Steady Amidst New Approval and Competitive Market
Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Erasca (ERAS)
Amphastar Pharmaceuticals (AMPH) Receives a Buy From Piper Sandler
Amphastar Pharma Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Cytokinetics (CYTK), Phibro Animal Health (PAHC) and Amphastar Pharmaceuticals (AMPH)
Amphastar Pharmaceuticals Poised for Growth: Strong Generic Pipeline and Strategic Marketing Drive Buy Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amphastar Pharmaceuticals (AMPH), Ascendis Pharma (ASND) and AMN Healthcare Services (AMN)
Amphastar Pharma Analyst Ratings
Needham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)
Teva Upgraded at J.P. Morgan on Upcoming Catalysts
Amphastar Pharma Analyst Ratings
Needham Remains a Hold on Amphastar Pharmaceuticals (AMPH)
Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Schrodinger (SDGR)
Piper Sandler Remains a Buy on Amphastar Pharmaceuticals (AMPH)
Analysis
Price Target
No Data
